Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SUPRIYA
₹876.50
₹867.00
₹887.50
₹545.50
₹1085.00
Markets Today
Historical Performance
As of 09-07-2026 17:15, Supriya Lifescience Ltd. share price today is ₹0, with a change of ₹-861.70 (-100.00%) from the previous close of ₹861.7. The stock opened at ₹867.7 and traded between ₹867 and ₹887.5, with a total traded volume of 341756 shares. The company has a market capitalization of ₹6779.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1085 and ₹545.5, respectively.
Supriya Lifescience Ltd. valuation metrics include a P/E ratio of 32.4, and book value of ₹5.70. Profitability indicators show ROE of 17.45% along with a dividend yield of 0.1%. Supriya Lifescience Ltd. has reported revenue of ₹827.88 Cr and net profit of ₹209.12 Cr.
Supriya Lifescience Ltd. technical indicators include Day RSI at 41.08, Day MFI at 39.97, Day ADX at 36.49. Additional indicators include Commodity Channel Index (CCI) at -245.2 and Williams %R at -96.68. Momentum indicators show Day MACD at 19.94, Day MACD Signal Line at 38.41, DayATR at 55.51. Rate of Change indicators for Supriya Lifescience Ltd. include ROC125 at 12.1 and ROC21 at -11.13.
Exponential moving averages include EMA5 at ₹910.9, EMA10 at ₹933.3, EMA12 at ₹935.4, EMA20 at ₹928.4, EMA26 at ₹915.5, EMA50 at ₹858.5, EMA100 at ₹792.6, EMA200 at ₹745.7. Simple moving averages include SMA5 at ₹938.2, SMA10 at ₹952.2, SMA20 at ₹948, SMA30 at ₹932.4, SMA50 at ₹840, SMA100 at ₹734.9, SMA150 at ₹733.3, SMA200 at ₹734.7.
Support levels for Supriya Lifescience are placed at First Support ₹824.27, Second Support ₹806.13, Third Support ₹776.77. Resistance levels are seen at First Resistance ₹871.77, Second Resistance ₹901.13, Third Resistance ₹919.27. Supriya Lifescience Ltd. shareholding pattern shows promoter holding at 68.3%, FII holding at 5.16%, DII holding at 0%, public holding at 20.83%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 276.53 | 206.44 | 199.83 | 145.07 | 184.11 |
| Operating Expense | 178.91 | 134.36 | 127.19 | 93.37 | 116.52 |
| Operating Profit | 97.62 | 72.08 | 72.65 | 51.70 | 67.58 |
| Depreciation | 8.50 | 6.82 | 6.64 | 6.45 | 6.08 |
| Interest | 0.47 | 0.49 | 0.42 | 0.51 | 0.42 |
| Tax | 17.90 | 17.24 | 17.89 | 12.62 | 13.68 |
| Net Profit | 74.23 | 49.68 | 50.43 | 34.79 | 50.38 |
₹876.50
↗ Bullish Moving Average
6
↘ Bearish Moving Average
10
| Held By |
|---|
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 4.5 L | 10.58 L | 42.56% |
| Week | 3.18 L | 8.93 L | 35.63% |
| 1 Month | 1.99 L | 5.39 L | 36.91% |
| 6 Month | 1.39 L | 3.86 L | 36.01% |
Companies with no Debt
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Consistent high performing stocks over Five Years
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2025 | 1 | FINAL | 05 Sep, 2025 | Equity Share |
| 20 Sep, 2024 | 0.8 | FINAL | Equity Share | |
| 15 Sep, 2023 | 0.6 | FINAL | Equity Share | |
| 01 Sep, 2022 | 0.6 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,027.20 | ₹807 | ₹1,418.10 | ₹1,625 | ₹4,508 | ₹660 |
| % Change | 2.41% | 0.84% | 0.59% | 0.81% | -0.69% | 1.95% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | ₹642.26 | ₹649.50 | ₹1,421.59 | ₹935 | ₹4,359.02 |
| Net Profit TTM (₹ Cr) | ₹185.12 | ₹172.89 | ₹115.38 | ₹-73.80 | ₹257.90 | ₹255.19 |
| PE TTM | 65.70 | 53.00 | 54.20 | -252.70 | 41.10 | 40.10 |
| 1 Year Return | 87.27 | 36.75 | 136.79 | -18.59 | -14.34 | 14.03 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 992.00
+0.93%
Blue Jet Healthcare Ltd
₹ 575.75
+2.32%
Concord Biotech Ltd.
₹ 1311.20
+4.08%
Aarti Pharmalabs Ltd.
₹ 704.00
+2.59%
Alivus Life Sciences Ltd.
₹ 1145.90
+1.40%
Cohance Lifesciences Ltd.
₹ 441.00
+2.37%
Eris Lifesciences Ltd.
₹ 1430.00
+0.99%
Syngene International Ltd.
₹ 415.85
+1.03%
Alembic Pharmaceuticals Ltd.
₹ 816.00
+0.58%
Sun Pharma Advanced Research Company Ltd.
₹ 278.05
+2.99%
Strides Pharma Science Ltd.
₹ 1072.00
-0.81%
FDC Ltd.
₹ 431.70
+1.96%
Shilpa Medicare Ltd.
₹ 624.80
+4.95%
Jubilant Pharmova Ltd.
₹ 972.00
+0.13%
Natco Pharma Ltd.
₹ 961.55
-0.49%
Caplin Point Laboratories Ltd.
₹ 2626.00
+3.86%
Marksans Pharma Ltd.
₹ 278.80
+5.83%
Orchid Pharma Ltd.
₹ 1050.00
+4.76%
Bliss GVS Pharma Ltd.
₹ 526.90
+2.72%
Sanofi India Ltd.
₹ 3349.00
-0.96%
Procter & Gamble Health Ltd.
₹ 6600.00
+5.39%
Jeena Sikho Lifecare Ltd.
₹ 590.00
+4.71%
By signing up I certify terms, conditions & privacy policy